cladribine has been researched along with Leukemia, Myelomonocytic, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammond, D; Montalban-Bravo, G | 1 |
| Bazinet, A; Borthakur, G; Chien, KS; Darbaniyan, F; Daver, NG; DiNardo, CD; Garcia-Manero, G; Hammond, D; Jabbour, EJ; Kadia, TM; Kanagal-Shamanna, R; Kantarjian, HM; Konopleva, MY; Montalban-Bravo, G; Pemmaraju, N; Pierce, SA; Ravandi, F; Sasaki, K; Venugopal, S | 1 |
1 review(s) available for cladribine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bridged Bicyclo Compounds, Heterocyclic; Cladribine; Disease Management; Drug Discovery; Humans; Leukemia, Myelomonocytic, Chronic; Molecular Targeted Therapy; Mutation; Sulfonamides; Treatment Outcome | 2021 |
1 other study(ies) available for cladribine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
Topics: Cladribine; Cytarabine; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Prospective Studies; Retrospective Studies | 2023 |